Assessing the influence of perfusion on cardiac microtissue maturation: A heart‐on‐chip platform embedding peristaltic pump capabilities

Abstract

Heart-on-chip is an unprecedented technology for recapitulating key biochemical and biophysical cues in cardiac pathophysiology. Several designs have been proposed to improve its ability to mimic the native tissue and establish it as a reliable research platform. However, despite mimicking one of most vascularized organs, reliable strategies to deliver oxygen and substrates to densely packed constructs of metabolically demanding cells remain unsettled. Herein, we describe a new hearton-chip platform with precise fluid control, integrating an on-chip peristaltic pump, allowing automated and fine control over flow on channels flanking a 3D cardiac culture. The application of distinct flow rates impacted on temporal dynamics of microtissue structural and transcriptional maturation, improving functional performance. Moreover, a widespread transcriptional response was observed, suggesting flow-mediated activation of critical pathways of cardiomyocyte structural and functional maturation and inhibition of cardiomyocyte hypoxic injury. In conclusion, the present design represents an important advance in bringing engineered cardiac microtissues closer to the native heart, overcoming traditional bulky off-chip fluid handling systems, improving microtissue performance, and matching oxygen and energy substrate requirements of metabolically active constructs, avoiding cellular hypoxia. Distinct flow patterns differently impact on microtissue performance and gene expression program.This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

LivHeart: A Multi Organ‐on‐Chip Platform to Study Off‐Target Cardiotoxicity of Drugs Upon Liver Metabolism

“…In turn, the NRCM construct viability resulted around 93% ± 2% at day 1 and 88% ± 2.5% at day 7 in µChannels device (Figure 2D(i)), and around 94% ± 1.5% at day 1 and 90% ± 2% at day 7 in the Valve device (Figure 2D(ii)). Such viability data are compatible with previous work on liver [20] and cardiac [21,22,25] cultures within microfluidic devices.…”

Current strategies of mechanical stimulation for maturation of cardiac microtissues

“…Intermittent cyclic compression yielded to a more aligned cellular morphology, compared to circular cell shape in continuously compressed tissues and better preserved key cardiomyocyte markers (α-actinin and n-cadherin) as compared to non-stimulated constructs. Other recent studies demonstrated the key role of physiological level of flow in improving functional performance and enhancing cellular alignment of both 2D and 3D systems (Cruz-Moreira et al 2021;Kobuszewska et al 2017).…”

Microfluidics: a concise review of the history, principles, design, applications, and future outlook

“…Researchers have developed organ-on-chip models (Fig. 14) for the brain, 208,209 gut, 207,210 heart, 211,212 eyes, 213,214 muscle, 215 lungs, 216,217 liver, 218,219 skin, 220 blood vessels, 221 etc.…”